Transport of the anti-cancer drug doxorubicin across cytoplasmic membranes and membranes composed of phospholipids derived from Escherichia coli occurs via a similar mechanism

This publication has 35 references indexed in Scilit:

• Verapamil competes with doxorubicin for binding to anionic phospholipids resulting in increased internal concentrations and rates of passive transport of doxorubicin
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1995
• Transport Studies of Doxorubicin in Model Membranes Indicate a Difference in Passive Diffusion across and Binding at the Outer and Inner Leaflet of the Plasma Membrane
  Biochemistry, 1994
• Transmembrane distribution of lipophilic cations in response to an electrochemical potential in reconstituted cytochromec oxidase vesicles and in vesicles exhibiting a potassium ion diffusion potential
  Journal of Bioenergetics and Biomembranes, 1994
• Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1993
• DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives
  Biochemistry, 1991
• Comparison of the membrane transport of anthracycline derivatives in drug‐resistant and drug‐sensitive K562 cells
  European Journal of Biochemistry, 1991
• Cell surface actions of adriamycin
  Pharmacology & Therapeutics, 1991
• Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity
  Biochemistry, 1990
• Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1986
• Kinetics of the daunomycin-DNA interaction
  Biochemistry, 1985